(Q33364465)

English

Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

phase II clinical trial

0 references

author name string

Gupta S

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Zhou P

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hassoun H

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kewalramani T

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Reich L

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Costello S

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Drake L

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Klimek V

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dhodapkar M

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Teruya-Feldstein J

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hedvat C

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kalakonda N

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Fleisher M

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Filippa D

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Qin J

15

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nimer SD

16

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Comenzo RL

17

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

441-447

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704779

0 references

Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

21 January 2018

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

21 January 2018

Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

21 January 2018

Single versus double autologous stem-cell transplantation for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

21 January 2018

Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

21 January 2018

Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

21 January 2018

Melphalan-mobilized blood stem cell components contain minimal clonotypic myeloma cell contamination.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

21 January 2018

Multiple myeloma and acute myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

21 January 2018

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

21 January 2018

The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

21 January 2018

Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

21 January 2018

Interleukin-6 is a major effector molecule of short-term G-CSF treatment inducing bone metabolism and an acute-phase response.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

21 January 2018

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

21 January 2018

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood progenitor cell transplantation in multiple myeloma following high-dose melphalan-based therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

Standard therapy versus autologous transplantation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous CD34-selected blood progenitor cell transplants for patients with advanced multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

A quantitative PCR assay for the detection of low amounts of malignant cells in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

Clonal immunoglobulin light chain variable region germline gene use in AL amyloidosis: association with dominant amyloid-related organ involvement and survival after stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

First and second apheresis in patients with multiple myeloma: no differences in tumor load and hematopoietic stem cell yield

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the kinetics of the bone marrow tumor load in the course of sequential high-dose therapy assessed by quantitative PCR as a predictive parameter in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

Mobilized CD34+ cells selected as autografts in patients with primary light-chain amyloidosis: rationale and application

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose intravenous melphalan for plasma-cell leukaemia and myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple myeloma treated with high dose intravenous melphalan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

Mobilization of CD34+ cells in elderly patients (>/= 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704779

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704779

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33364465&oldid=1536604952"